Genscript Biotech (OTCMKTS:GNNSF) Shares Down 15.5% – Here’s What Happened

Genscript Biotech Co. (OTCMKTS:GNNSF)’s share price fell 15.5% during trading on Monday . The company traded as low as C$1.31 and last traded at C$1.31. 200 shares were traded during mid-day trading, a decline of 98% from the average session volume of 9,917 shares. The stock had previously closed at C$1.55.

Genscript Biotech Price Performance

The company has a 50-day moving average price of C$1.75 and a two-hundred day moving average price of C$2.03.

Genscript Biotech Company Profile

GenScript Biotech Corporation is a global contract research, development and manufacturing organization (CDMO) specializing in synthetic biology and biopharmaceutical services. Founded in 2002, the company provides end-to-end solutions that span gene and peptide synthesis, recombinant protein expression, custom antibody discovery and cell line development. GenScript’s integrated platforms support early-stage discovery through to process development, enabling academic institutions, biotech innovators and pharmaceutical companies to accelerate research timelines.

The company’s core offerings include molecular biology services such as DNA construction, gene editing using CRISPR/Cas9 technology and high-throughput peptide libraries.